A Study of DII235 in Adults With Elevated Lipoprotein(a)

Clinical trial NCT07235046 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07235046
Sponsor: Novartis Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lipoprotein Disorder

Start date: 2025-12-02
Primary completion: 2027-04-26
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.